Loss of PD-L1 expression in metastatic Merkel cell carcinoma strongly correlates with a poor prognosis

被引：0
|
作者：
Nakamura, M. [1 ]
Teramoto, Y. [2 ]
Yasuda, M. [3 ]
Wada, H. [4 ]
Ozawa, T. [5 ]
Umemori, Y. [6 ]
Ogata, D. [7 ]
Kobayashi, T. [8 ]
Hata, M. [9 ]
Morita, A. [1 ]
机构：
[1] Nagoya City Univ, Nagoya, Aichi, Japan
[2] Saitama Med Univ, Int Med Ctr, Hidaka, Japan
[3] Gunma Univ, Maebashi, Gunma, Japan
[4] Yokohama City Univ, Yokohama, Kanagawa, Japan
[5] Osaka City Univ, Osaka, Japan
[6] Nagaoka Red Cross Hosp, Nagaoka, Niigata, Japan
[7] Saitama Med Univ, Irima, Japan
[8] Kanazawa Univ, Kanazawa, Ishikawa, Japan
[9] Gifu Prefectural Gen Med Ctr, Gifu, Japan
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
131
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [1] High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma
    Lin, Yueh-Min
    Sung, Wen-Wei
    Hsieh, Ming-Ju
    Tsai, Shih-Chen
    Lai, Hung-Wen
    Yang, Shu-Mei
    Shen, Ko-Hong
    Chen, Mu-Kuan
    Lee, Huei
    Yeh, Kun-Tu
    Chen, Chih-Jung
    [J]. PLOS ONE, 2015, 10 (11):
  • [2] PD-L1 Expression is Associated With Poor Prognosis in Renal Cell Carcinoma
    Carlsson, Jessica
    Sundqvist, Pernilla
    Kosuta, Vezira
    Falt, Anna
    Giunchi, Francesca
    Fiorentino, Michelangelo
    Davidsson, Sabina
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (03) : 213 - 220
  • [3] PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma
    Gaiser, Maria Rita
    Bongiorno, Michelle
    Brownell, Isaac
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (04) : 345 - 359
  • [4] Prognostic value of PD-L1 expression in Merkel cell carcinoma
    Nakamura, Motoki
    Kobayashi, Yuka
    Kato, Hiroshi
    Watanabe, Shoichi
    Yasuda, Masahito
    Umemori, Yukie
    Ogata, Dai
    Kobayashi, Tadahiro
    Hata, Maiko
    Morita, Akimichi
    [J]. CANCER SCIENCE, 2018, 109 : 1340 - 1340
  • [5] Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma
    Yeo, Min-Kyung
    Choi, Song-Yi
    Seong, In-Ock
    Suh, Kwang-Sun
    Kim, Jin Man
    Kim, Kyung-Hee
    [J]. HUMAN PATHOLOGY, 2017, 68 : 103 - 111
  • [6] Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma
    Hanna, Glenn J.
    Kacew, Alec J.
    Tanguturi, Anusha R.
    Grote, Hans J.
    Vergara, Victoria
    Brunkhorst, Beatrice
    Rabinowits, Guilherme
    Thakuria, Manisha
    LeBoeuf, Nicole R.
    Ihling, Christian
    DeCaprio, James A.
    Lorch, Jochen H.
    [J]. FRONTIERS IN MEDICINE, 2020, 7
  • [7] PD-L1 in circulating exosomes of Merkel cell carcinoma
    Zanella, Anais
    Vautrot, Valentin
    Aubin, Francois
    Avoscan, Laure
    Samimi, Mahtab
    Garrido, Carmen
    Gobbo, Jessica
    Nardin, Charlee
    [J]. EXPERIMENTAL DERMATOLOGY, 2022, 31 (06) : 869 - 877
  • [8] PD-L1 expression is common and indicates poor prognosis
    Clemens Thoma
    [J]. Nature Reviews Urology, 2016, 13 (1) : 5 - 5
  • [9] PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
    Lipson, Evan J.
    Vincent, Jeremy G.
    Loyo, Myriam
    Kagohara, Luciane T.
    Luber, Brandon S.
    Wang, Hao
    Xu, Haiying
    Nayar, Suresh K.
    Wang, Timothy S.
    Sidransky, David
    Anders, Robert A.
    Topalian, Suzanne L.
    Taube, Janis M.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2013, 1 (01) : 54 - 63
  • [10] Tumor PD-L1 expression is correlated with increased TILs and poor prognosis in penile squamous cell carcinoma
    Deng, Chuangzhong
    Li, Zaishang
    Guo, Shengjie
    Chen, Peng
    Chen, Xiaofeng
    Zhou, Qianghua
    Chen, Jieping
    Yu, Xingsu
    Wu, Xiaoliang
    Ma, Wenjuan
    Xie, Qiankun
    Ye, Yunlin
    Li, Yonghong
    Qin, Zike
    Liu, Zhuowei
    Liu, Ranyi
    Zhang, Zhenfeng
    Yao, Kai
    Han, Hui
    Zhou, Fangjian
    [J]. ONCOIMMUNOLOGY, 2017, 6 (02):
12345